Orexigen Rises After Update On 2017 Priorities
January 05, 2017 at 17:36 PM EST
Shares of Orexigen Therapeutics are on the rise after the company provided an update on recent progress and its key business priorities for 2017 to boost the sales of its two diet pill products, Contrave and Mysimba.
